REFERENCES
- El Saleh F., Kleinebudde P. Mercury-free determination of apparent density and porosity of pellets by powder pycnometry. Pharm. Tech. Europe 1998; 10: 18–26, [CSA]
- Ghebre-Sellassie I. Pellets: General overview. Pharmaceutical pelletization technology, I. Ghebre-Sellassie. Informa UK Ltd, New York 1989; 1–14
- Harris M. R., Ghebre-Sellassie I. Formulation variables. Pharmaceutical pelletization technology, I. Ghebre-Sellassie. Informa UK Ltd, New York 1989; 217–239
- Haznos L., Langer I., Gyamathy M. Some factors influencing pellet characteristics made by extrusion/spheronization process: effect on size characteristics and moisture content decrease of pellets. Drug Dev. Ind. Pharm. 1992; 18: 409–437, [CSA]
- Heng P. W. S., Liew C. V., Gu L. Influence of teardrop studs on rotating frictional base plate on spheroid quality in rotary spheronization. Int. J. Pharm. 2002; 241: 173–184, [INFOTRIEVE], [CSA], [CROSSREF]
- Ho H., Liu Ch., Lin H., Sheu M. The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation. J. Contr. Rel. 1997; 49: 149–156, [CSA], [CROSSREF]
- Kim H., Fassihi R. Application of a binary polymer system in drug release rate modulation: 2. Influence of formulation variables and hydrodynamic conditions of release kinetics. J. Pharm. Sci. 1997; 86: 323–328, [INFOTRIEVE], [CSA], [CROSSREF]
- Kristensen J., Schaefer T., Kleinebudde P. Direct pelletization in a rotary processor controlled by torque measurements. Pharm. Dev. Technol. 2000; 5: 247–256, [INFOTRIEVE], [CSA], [CROSSREF]
- Liew C. V., Wan L. S. C., Heng P. W. S. Role of base plate rotational speed in controlling spheroid size distribution and minimizing oversize particle formation during spheroid production by rotary processing. Drug Dev. Ind. Pharm. 2000; 26: 953–963, [INFOTRIEVE], [CSA], [CROSSREF]
- Martin A., Swarbrick J., Cammarata A. Kinetics. Physical Pharmacy, A. Martin. Informa UK Ltd, Philadelphia 1983; 352–398
- Rabišková M. Extrusion technology. Microencapsulation of food ingredients, P. Vilstrup. Informa UK Ltd, Surrey 2001; 224–248
- Rowe R. C., Sheskey P. J., Weller P. J. Handbook of Pharmaceutical Excipients. Informa UK Ltd, London 2003
- Sienkiewicz G., Pereira R., Rudnic E. M., Lausier J. M., Rhodes C. T. Spheronization of theophylline—Avicel combinations using a fluidized-bed rotogranulation technique. Drug Dev. Ind. Pharm. 1997; 23: 173–182, [CSA]
- Stewart P. J., Zhao F. Understanding agglomeration of indomethacin during the dissolution of micronized indomethacin mixtures through dissolution and de-agglomeration modeling approaches. Eur. J. Pharm. Biopharm. 2005; 59: 315–323, [INFOTRIEVE], [CSA], [CROSSREF]
- Vertommen J., Kinget R. The influence of five selected processing and formulation variables on the particle size, particle size distribution and friability of pellets produced in a rotary processor. Drug Dev. Ind. Pharm. 1997; 23: 39–46, [CSA]
- Vetchý D., Rabišková M. Some variables influencing rotoagglomeration in the multiprocessor MP-1. Int. J. Pharm. 2002; 242: 353–356, [CSA], [CROSSREF]